1,076,714 results match your criteria: "France ; Universite Paris Diderot[Affiliation]"
Sci Rep
January 2025
Department of Physical Education, States University of Pará, Pará, Brazil.
It is well known that elite athletes of specific ethnicities and/or nationalities dominate certain sports disciplines (e.g., East Africans in marathon running).
View Article and Find Full Text PDFSci Rep
January 2025
Strathclyde Institute of Education, University of Strathclyde, Lord Hope Building, Glasgow, G4 0LT, UK.
Computational analysis of infant movement has significant potential to reveal markers of developmental health. We report two studies employing dynamic analyses of motor kinematics and motor behaviours, which characterise movement at two levels, in 9-month-old infants. We investigate the effect of preterm birth (< 33 weeks of gestation) and the effect of changing emotional and social-interactive contexts in the still-face paradigm.
View Article and Find Full Text PDFSci Rep
January 2025
Oeschger Centre for Climate Change Research (OCCR), University of Bern, Bern, Switzerland.
The impacts of climate change on human health are often underestimated or perceived to be in a distant future. Here, we present the projected impacts of climate change in the context of COVID-19, a recent human health catastrophe. We compared projected heat mortality with COVID-19 deaths in 38 cities worldwide and found that in half of these cities, heat-related deaths could exceed annual COVID-19 deaths in less than ten years (at + 3.
View Article and Find Full Text PDFNat Commun
January 2025
Institute of Biological Information Processing, IBI-2: Mechanobiology, Research Centre Juelich, Juelich, Germany.
Targeting of diseased cells is one of the most urgently needed prerequisites for a next generation of potent pharmaceuticals. Different approaches pursued fail mainly due to a lack of specific surface markers. Developing an RNA-based methodology, we can now ensure precise cell targeting combined with selective expression of effector proteins for therapy, diagnostics or cell steering.
View Article and Find Full Text PDFHomozygous MTAP deletion occurs in ~15% of cancers, making them vulnerable to decreases in the concentration of S-adenosylmethionine (SAM). AG-270/S095033 is an oral, potent, reversible inhibitor of methionine adenosyltransferase 2 A (MAT2A), the enzyme primarily responsible for the synthesis of SAM. We report results from the first-in-human, phase 1 trial of AG-270/S095033 as monotherapy in patients with advanced malignancies (ClinicalTrials.
View Article and Find Full Text PDFNat Commun
January 2025
Laboratoire Sciences et Ingénierie de la Matiére Molle, ESPCI Paris, CNRS, PSL University, Paris, France.
Stretchable elastic materials with high strength, toughness, and good ionic conductivity are highly desirable for wearable devices and stretchable batteries. Unfortunately, limited success has been reported to attain all of these properties simultaneously. Here, we report a family of ionically conductive elastomers (ICEs) without compromise between mechanical properties (high stiffness, reversible elasticity, fracture resistance) and ionic conductivity, by introducing a multiple network elastomer (MNE) architecture into a low polymer.
View Article and Find Full Text PDFNat Commun
January 2025
Matériaux et Phénomènes Quantiques, Université Paris Cité, CNRS UMR 7162, Paris, France.
We present an optomechanical method for locally measuring the rheological properties of complex fluids in the ultra-high frequency range (UHF). A mechanical disk of microscale volume is used as an oscillating probe that monitors a liquid at rest, while the oscillation is optomechanically transduced. An analytical model for fluid-structure interactions is used to deduce the rheological properties of the liquid.
View Article and Find Full Text PDFDrug Test Anal
January 2025
Hemarina SA, Aeropôle Centre, Morlaix, France.
The natural extracellular hemoglobin of the lugworm Arenicola marina (AmHb) has many interesting characteristics: It carries 40 times more oxygen than human hemoglobin; has anti-inflammatory, antibacterial, and antioxidant properties; and is 250 times smaller than a red blood cell. It is nontoxic and nonimmunogenic. It is thus a very promising hemoglobin-based oxygen carrier.
View Article and Find Full Text PDFRMD Open
January 2025
Service de Rhumatologie, Hôpital Cochin, APHP-Centre Université Paris Cité, Paris, France
Objective: To examine the course of interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in France on treatment with Janus kinase inhibitors (JAKis) using the MAJIK-SFR registry.
Methods: Prospective national multicentre observational study identifying patients with RA-ILD from the MAJIK-SFR registry. Pulmonary assessment data were collected at JAKi initiation and follow-up visits (6 months, 12 months and a median of 21 months postinclusion), including chest high-resolution CT (HRCT), pulmonary function tests (forced vital capacity (FVC) and diffusing capacity of the lungs for carbon monoxide (DLCO)), acute exacerbations of ILD, respiratory infections and lung cancers.
J Immunother Cancer
January 2025
Paris-Saclay University, Gif-sur-Yvette, Île-de-France, France
Background: Nivolumab is an immune checkpoint inhibitor (ICI) that selectively inhibits programmed cell death protein 1 activation, restoring antitumor immunity. ICIs are indicated for various types of advanced solid tumors; however, not all patients benefit from them, and tools that could be used in the clinic to predict response to treatment represent an unmet need. Here we describe the development of a new population pharmacokinetic (PPK) model in patients treated with nivolumab in clinical trials.
View Article and Find Full Text PDFBMJ
January 2025
Biostatistics Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Eur J Haematol
January 2025
Department of Hematology, Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, CNRS, Aix-Marseille University, Marseille, France.
Acute myeloid leukemias (AMLs) are the hematological malignancies with the highest need for intensive care unit (ICU) admission due to their association with various life-threatening situations. Limited data exist regarding the outcomes of elderly individuals with AML admitted to the ICU. However, current therapeutic protocols offer the potential for extended survival in this population.
View Article and Find Full Text PDFGastroenterology
January 2025
Université Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-75018 Paris, France; Department of Pathology, APHP Nord, FHU MOSAIC, Beaujon Hospital, Clichy, France. Electronic address:
World Neurosurg
January 2025
Department of Neurosurgery, Hopital Bretonneau, Tours, France. Electronic address:
Purpose: Lumbar disc herniation, canal stenosis and cervicarthrosis are degenerative spinal pathologies frequently observed in the aging population of patients with Parkinson Disease (PD). Spinal surgery in PD patients remains risky with uncertain functional results. The main issue is to determine whether a surgical procedure should be performed on PD patients with common degenerative spinal pathologies (CDSP).
View Article and Find Full Text PDFDiabetes Res Clin Pract
January 2025
Department of Endocrinology-Diabetology-Nutrition, Jean Verdier Hospital, APHP, CINFO, Bondy, France. Electronic address:
Although often overlooked sleep apnea has emerged as a significant public health concern. Obstructive sleep apnea (OSA) and diabetes commonly co-exist with a vicious cycle worsening the incidence and severity of both conditions. OSA has many implications including cardiometabolic disorders and impaired cardiovascular (CV) prognosis.
View Article and Find Full Text PDFJ Infect Dis
January 2025
Institut Pasteur, Université de Paris Cité, Virus and Cellular Stress Unit, Department of Virology, Paris, France.
Background: Restriction factors are host cell proteins that play a role in limiting virus replication. They form part of the intrinsic immune system and function as a first line of defense against viral infections. Hepatitis B virus (HBV) does not escape this rule and TREX1, a host restriction enzyme acts as an antiviral factor, leading to the inhibition of the virus.
View Article and Find Full Text PDFRev Esp Cardiol (Engl Ed)
January 2025
Department of Cardiology, Internal Medicine II, Medical University of Vienna, Vienna, Austria. Electronic address:
Introduction And Objectives: Patients undergoing percutaneous coronary intervention in vessels with moderate-to-severe tortuosity are at higher risk of adverse outcomes, but data are scarce in the era of newer-generation stents. We compared outcomes following percutaneous coronary intervention in vessels with moderate-to-severe tortuosity using a bioresorbable-polymer sirolimus-eluting stent (BP-SES) vs a durable-polymer everolimus-eluting stent.
Methods: A total of 2350 patients from the BIOFLOW II, IV, and V randomized trials were stratified into 2 groups based on target-vessel tortuosity: none-to-mild and moderate-to-severe.
Hand Surg Rehabil
January 2025
Department of Orthopedic, Trauma and Hand Surgery, Hôpital Saint-Antoine, Sorbonne University, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France.
J Infect
January 2025
Microbiology department, Necker-Enfants malades Hospital, AP-HP, Université Paris Cité, Paris, France; Université Paris Cité, URP 7328 FETUS, Paris, France.
Background: A Parvovirus B19 (B19V) outbreak has been reported in Europe in 2023-2024. The aims of this study were 1) to describe the incidence of primary cases from 2012 to 2024 in one French hospital 2) to analyze the genome of 2023 strains 3) to identify virological profiles according to the clinical presentations of B19V infection.
Methods: The incidence of B19V primary cases was studied through an interrupted time-series analysis.
Mol Biol Evol
January 2025
Universite Claude Bernard Lyon 1, LBBE, UMR 5558, CNRS, VAS, Villeurbanne, F-69622, France.
Phylogenetic inference is mainly based on sequence analysis and requires reliable alignments. This can be challenging, especially when sequences are highly divergent. In this context, the use of three-dimensional protein structures is a promising alternative.
View Article and Find Full Text PDFBr J Dermatol
January 2025
Service de dermatologie, Hôpital Saint Louis, AP-HP, Université Paris Cité, Paris, France.
Alcohol Alcohol
November 2024
Univ. Rennes, CREM (UMR CNRS 6211), 11 rue Jean Macé, F-35000 Rennes, France.
Aims: Exposure to alcohol marketing is associated with higher alcohol consumption. In recent years, a growing number of modern labels have appeared on alcohol bottles. Unlike traditional labels that typically convey factual details about a product, such as product type, quality, origin, and brewery creation date, modern labels are designed to create an imaginary, often quirky universe that is disconnected from the product itself.
View Article and Find Full Text PDFBr J Haematol
January 2025
Département de Biochimie-Pharmacologie, APHP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France.
Phys Med Biol
January 2025
CNRS, BAOBAB, CEA, NeuroSpin, Université Paris-Saclay, Gif-sur-Yvette, 91191, FRANCE.
Ultra-high field MRI with parallel transmission (pTx) provides a powerful neuroimaging tool with potential application in paediatrics. The use of pTx, however, necessitates a dedicated local specific absorption rate (SAR) management strategy, able to predict and monitor the peak local SAR (pSAR). In this work, we address the pSARassessment for an in-house built 7 Tesla 16Tx32Rx pediatric head coil, using the concept of Virtual Observation Points (VOPs) for SAR estimation.
View Article and Find Full Text PDFLung Cancer
December 2024
Thoracic Surgery, Royal Brompton and Harefield Hospitals, Part of Guy's and St Thomas' NHS Foundation Trust, London, UK.
Background: Pathologic confirmation of lung cancer influences treatment selection for suspected early-stage lung cancer. High pre-treatment tissue confirmation rates are recommended. We sought to define management and outcomes of patients undergoing surgery for primary lung cancer in a UK multi-centre clinical trial.
View Article and Find Full Text PDF